Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 775 of 1294 entries
View as:

A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06716307 Org: User:
Start: 12/02/24 End: 03/28/25 Due: 03/28/26

A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level

Phase: N/A Priority: Normal
NCT ID: NCT06153537 Org: User:
Start: 11/29/23 End: 03/24/25 Due: 03/24/26

Evaluation of Safety and Parameters of Application Technique

Phase: N/A Priority: Normal
NCT ID: NCT01516242 Org: User:
Start: 10/31/06 End: 12/31/07 Due: 12/31/08

Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00624364 Org: User:
Start: 05/31/04 End: 05/31/05 Due: 05/31/06

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01967589 Org: User:
Start: 10/31/13 End: 05/31/14 Due: 05/31/15

Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02016911 Org: User:
Start: 12/12/13 End: 01/12/15 Due: 01/12/16

Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

Phase: N/A Priority: Normal
NCT ID: NCT03435627 Org: User:
Start: 02/26/18 End: 01/18/22 Due: 01/18/23

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00696995 Org: User:
Start: 01/31/07 End: 09/30/08 Due: 09/30/09

Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00184665 Org: User:
Start: 06/30/04 End: 09/30/06 Due: 09/30/07

Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01572753 Org: User:
Start: 04/12/12 End: 09/08/12 Due: 09/08/13

A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers

Phase: N/A Priority: Normal
NCT ID: NCT05790681 Org: User:
Start: 04/25/23 End: 02/08/24 Due: 02/08/25

A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

Phase: N/A Priority: Normal
NCT ID: NCT06288412 Org: User:
Start: 02/26/24 End: 04/14/25 Due: 04/14/26

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02420262 Org: User:
Start: 07/26/15 End: 10/05/16 Due: 10/05/17

Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00972283 Org: User:
Start: 09/01/09 End: 10/28/10 Due: 10/28/11

Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00832182 Org: User:
Start: 12/22/99 End: 11/25/02 Due: 11/25/03

Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06403761 Org: User:
Start: 05/06/24 End: 12/18/25 Due: 12/18/26

Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01548235 Org: User:
Start: 02/28/06 End: 04/30/07 Due: 04/30/08

A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04102189 Org: User:
Start: 10/07/19 End: 03/28/22 Due: 03/28/23

Comparison of Two NN1250 Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00966368 Org: User:
Start: 08/31/09 End: 10/31/09 Due: 10/31/10

Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01518062 Org: User:
Start: 11/30/89 End: 09/30/03 Due: 09/30/04

In-market Utilisation of Liraglutide Used for Weight Management in Europe

Phase: N/A Priority: Normal
NCT ID: NCT02967757 Org: User:
Start: 12/22/16 End: 05/28/19 Due: 05/28/20

A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05872022 Org: User:
Start: 07/05/23 End: 12/30/32 Due: 12/30/33

Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01563523 Org: User:
Start: 03/31/02 End: 10/31/03 Due: 10/31/04

A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT05053139 Org: User:
Start: 12/02/21 End: 12/17/24 Due: 12/17/25

A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin

Phase: N/A Priority: Normal
NCT ID: NCT01713530 Org: User:
Start: 02/21/13 End: 01/09/14 Due: 01/09/15